Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer

Real-world evidence from clinical practices is fundamental for understanding the efficacy and tolerability of medicinal products. Patients with renal cell cancer were studied to gain data not represented by analyses conducted on highly selected patients participating in clinical trials. Our goal was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathol Oncol Res
Autors principals: Küronya, Zsófia, Szőnyi, Mihály Dániel, Nagyiványi, Krisztián, Gyergyay, Fruzsina, Géczi, Lajos, Budai, Barna, Martin, Tamás, Ladányi, Andrea, Kiss, Edina, Biró, Krisztina
Format: Artigo
Idioma:Inglês
Publicat: Springer Netherlands 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471165/
https://ncbi.nlm.nih.gov/pubmed/32572819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-020-00853-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars